Correction: LabTech launches MicroStreak in US

By ALS staff
Friday, 13 June, 2008

In our online story LabTech launches MicroStreak in the US on June 11, we incorrectly stated that LabTech Systems had received royalties from sales.

The company is anticipating royalties but they have not been received yet. LabTech Systems has instead received licence payments of $4.9 million to date from licencee bioMerieux, and is entitled to receive up to a total of $11.2 million.

The original story has been corrected. We apologise for the error.

Related News

No clear link between paracetamol in pregnancy and autism/ADHD

Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with...

Light at night can increase heart disease risk

Being exposed to bright light at night can significantly increase your chances of developing...

Scientists find new driver of ovarian cancer spread

A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd